Automatically performing irreversible electroporation ablation during heart refractory period
AssigneeBiosense Webster (Israel) Ltd.
InventorAssaf Govari
Life of this patent
Estimating the term…
Abstract
A method includes inserting an ablation catheter into an ablation site in a patient heart. Multiple electrocardiogram (ECG) signals are acquired. A refractory period of the patient heart is detected based on the acquired ECG signals. The ablation site is ablated using the ablation catheter during the detected refractory period.
Claims18
A method for performing irreversible electroporation during heart refractory period, the method comprising:
- inserting an ablation catheter into an ablation site in a patient heart;
- acquiring multiple electrocardiogram (ECG) signals;
- detecting, based on the acquired ECG signals, a refractory period of the patient heart;
- and
- ablating the ablation site using the ablation catheter during the detected refractory period.
A system for performing irreversible electroporation during heart refractory period, the system comprising:
- one or more electrodes, which are configured to sense multiple electrocardiogram (ECG) signals of a patient heart;
- and
- a processor, which is configured, based on the acquired ECG signals, to detect a refractory period of the patient heart, and to control ablation at an ablation site during the detected refractory period.
A system for performing irreversible electroporation during heart refractory period, the system comprising:
- an interface, which is configured to receive multiple electrocardiogram (ECG) signals of a patient heart;
- and
- a processor, which is configured, based on the received ECG signals, to detect a refractory period of the patient heart, and to control ablation at the ablation site during the detected refractory period.
Dependencies are inferred from the claim text.